We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Health Canada has finalized guidance on software as a medical device (SaMD) that clarifies how it fits into the agency’s regulatory framework and how devicemakers can comply. Read More
The device for use by patients that cannot move independently and must stay in a prone or supine position, will continue to be seen as Class II, the agency said. Read More
Labeling should include information on indications, contraindications, warnings, product information and directions for use, the agency said. Read More
Devicemakers should ensure their devices are designed and manufactured such that the risks associated with “reasonably foreseeable environmental conditions” are removed or minimized. Read More
The committee met in 2019 to discuss how healthcare providers and the agency should communicate medical device cybersecurity risks to patients and the public. Read More
The FDA has released a new draft guidance that lays out a step-by-step process for applying data from a previously approved delivery system, a practice commonly known as bridging, to an application for a combination product. Read More
Health Canada has finalized guidance on software as a medical device (SaMD) that clarifies how it fits into the agency’s regulatory framework and how devicemakers can comply. Read More